Neuron WavesNeuron Waves
Parkinson's News

The latest in Parkinson's research

Real, recent developments in Parkinson's disease — research, therapies, and diagnostics — curated and summarised, with a link to every original source.

Stylised 3D model of a human brain on a purple gradientResearch

Blocking a brain immune protein may slow how Parkinson's spreads

Penn researchers found that the brain's own immune cells pump out a protein, GPNMB, that helps Parkinson's damage jump between neurons — and antibodies can interrupt it.

Read more
Researcher pipetting coloured samples into vials in a laboratoryStem cells

Engineered stem cells implanted to restore dopamine in Parkinson's patients

An early-phase trial is implanting lab-grown dopamine neurons directly into patients' brains to replace the cells lost to Parkinson's.

Read more
Glowing X-ray-style image of a human brain on a black backgroundResearch

Scientists identify a hidden protein interaction that drives Parkinson's

Researchers found that alpha-synuclein hijacks a mitochondrial enzyme — and built a decoy compound, CS2, that blocks the harmful interaction.

Read more
Modern clinical research laboratory bench with a microscopeClinical trials

Two new Parkinson's therapies reach the final stage of clinical trials

A new oral dopamine drug (tavapadon) and a stem-cell therapy (bemdaneprocel) are both advancing through late-stage trials toward possible approval.

Read more
Automated laboratory equipment bathed in blue lightFunding

Parkinson's research gets a $4 million funding boost

The APDA committed $4.04M for 2025–2026 — a 55% increase — spanning new therapies, brain-circuit science, and research equity.

Read more
Smartwatch displaying colourful health and activity appsDiagnostics

Voice, finger-tapping and gait: AI spots early Parkinson's from a phone

A multimodal AI model that combines smartphone voice, finger-tapping and gait data flagged early-stage Parkinson's with strong accuracy.

Read more

Summaries are written in-house; full articles remain on their original publishers' sites.